Cerevel Therapeutics Holdings, ( CERE) - Stock Earnings
Stock symbol CERE is outdated, potentially delisted? Maybe it is available on other exchange?
CERE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -99.5 million USD | — USD |
| 2023Q3 | -96.4 million USD | — USD |
| 2023Q4 | -132.7 million USD | — USD |
CERE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -222.4 million USD | 0 USD |
| 2022 | -351.5 million USD | 0 USD |
| 2023 | -432.8 million USD | — USD |
CERE
Price: $44.96
52 week price:
Earnings Per Share: -2.73 USD
P/E Ratio: -17.17
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 300700
Market Capitalization: 7.5 billion